Filing Flows › Coya Therapeutics (COYA) › Q1 2026 › vs Q4 2025
Coya Therapeutics (COYA) Q1 2026 vs Q4 2025 (quarter over quarter)
Coya Therapeutics's revenue fell $3.7M (-94%) from $4.0M in Q4 2025 to $251K in Q1 2026.
Coya Therapeutics, Q1 2026: revenue $251K (-3% year over year), net loss $7.2M, operating cash flow −$6.2M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $251K | $4.0M | −$3.7M | -94% |
| Other income, net | $433K | $322K | $111K | +34% |
| Net loss | $7.2M | $5.7M | $1.5M | +26% |
| Costs & expenses | $7.9M | $10.0M | −$2.1M | -21% |
| Operating costs | $7.9M | $10.0M | −$2.1M | -21% |
| Research & development | $4.1M | $4.9M | −$844K | -17% |
| General & admin | $3.8M | $3.3M | $512K | +16% |
| Operating cash sources | $8.4M | $2.1M | $6.3M | +297% |
| Depreciation | $3K | $7K | −$4K | -59% |
| Share-based compensation | $2.2M | $1.1M | $1.1M | +99% |
| Cash used in operations | $6.2M | $1.0M | $5.2M | +516% |
| Net loss absorbed | $7.2M | $5.7M | $1.5M | +26% |
| Working capital & other | $1.2M | −$3.6M | $4.8M | — |
Questions
How much did Coya Therapeutics's revenue grow quarter over quarter in Q1 2026?
Coya Therapeutics's revenue fell $3.7M (-94%) from $4.0M in Q4 2025 to $251K in Q1 2026.